<DOC>
	<DOCNO>NCT01982812</DOCNO>
	<brief_summary>Pediatric cerebral malaria ( CM ) affect 3 million child year kill ~20 % leave one third survivor long term neurologic psychiatric sequela . Seizures occur commonly CM associate increase risk death neuropsychiatric disability . In Malawi-based , safety feasibility study enteral levetiracetam pediatric CM , investigator lay groundwork future efficacy study aim improving seizure control ultimately decrease neurologic morbidity pediatric CM .</brief_summary>
	<brief_title>A Safety Feasibility Study Enteral LVT vs. Standard Care Seizure Control Pediatric CM</brief_title>
	<detailed_description>Cerebral malaria ( CM ) affect ~3 million child year , primarily sub-Saharan Africa . Antimalarial medication rapidly clear P. falciparum parasite , mortality rate remain high ( 12-25 % ) . Survivors escape unscathed -- ~30 % experience neurologic sequela include epilepsy , behavioral disorder gross neurologic deficit . Acute seizures occur commonly CM associate high neurologic morbidity mortality . Seizure management malaria endemic region challenge available antiepileptic drug ( AED ) induce respiratory suppression assist ventilation unavailable . More optimal seizure control may improve neurologic outcome pediatric CM survivor , especially medication use affordable deliver safely easily resource limited setting . The investigator conduct dose- escalation study detail elsewhere ( NCT01660672 ) determine optimal dose use safety feasibility study enteral levetiracetam ( LVT ) seizure control child CM seizure admit Queen Elizabeth Central Hospital Blantyre , Malawi . Enteral LVT give via nasogastric tube ( NGT ) rather intravenous ( IV ) formulation use since LVT excellent enteral bioavailability IV formation affordable malaria-endemic region . LVT 40mg/kg follow 30mg per kg Q12 hourly . Children admit cerebral malaria seizure randomize LVT vs. standard care phenobarbital need comparing seizure control , safety , neurological outcome .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Malaria , Cerebral</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Comatose Blantyre Comas Score â‰¤ 2 P. falciparum parasitemia via thick blood film rapid diagnostic test Active seizure past 24 hour Serum creatinine &gt; 2mg/dL Preadmission/concomitant treatment antiretroviral medication HIV ( ARVs ) , antituberculous treatment ( ATTs ) , chronic use enzymeinducing medication</criteria>
	<gender>All</gender>
	<minimum_age>24 Months</minimum_age>
	<maximum_age>83 Months</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>